Table 3.
Comparison of intermediate-term adverse prognosis between two groups
| Variable | the Tyg index ≤ 9.04 (n = 315) |
the Tyg index > 9.04 (n = 318) |
P value |
|---|---|---|---|
| MACE, n (%) | 31 (9.8) | 68 (21.4) | < 0.001 |
| All-cause death, n (%) | 13(4.1) | 22 (6.9) | 0.124 |
| Cardiac death, n (%) | 9 (2.9) | 12 (3.8) | 0.520 |
| Myocardial infarction, n (%) | 9 (2.9) | 11 (3.5) | 0.665 |
| Unplanned revascularization, n (%) | 16 (5.1) | 48 (15.1) | < 0.001 |
| Stroke, n (%) | 14 (4.4) | 8 (2.5) | 0.180 |
Data are presented as n (%)
MACEs major adverse cardiac events, TyG index the triglyceride–glucose index.